From the 1Experimental Therapeutics and Pathophysiology Branch, NIMH-NIH
2Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD
3Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada
Departments of 4Psychiatry
5Pharmacology and Anatomy & Neurobiology, University of Maryland School of Medicine
6Veterans Affairs Maryland Health Care System, Baltimore, MD.
Received September 6, 2022; accepted after revision December 15, 2022.
Address correspondence to: Carlos A. Zarate Jr, MD, Experimental Therapeutics and Pathophysiology Branch, NIMH-NIH, 10 Center Drive, MSC 1282 Building 10CRC, Room 7-5342, Bethesda, MD 20892 (e-mail: [email protected]).
B.Q. and G.C.M. share first-authorship.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.psychopharmacology.com).
A podcast discussing this article is available online at the journal website.